Pharmaceuticals Industry Market Index
The Pharmaceuticals Industry in the Health Care Sector includes companies engaged in the research, development, or production of pharmaceuticals (including veterinary drugs).
The Pharmaceuticals industry index is a market composite index that includes 16 stocks from public trading companies and ADRs with the largest market capitalizations in the Pharmaceuticals industry.
The list of stocks in the Pharmaceuticals industry includes Roche Holding AG, Bristol-Myers Squibb Co, Eli Lilly and Co, Novartis AG, Roche Holding AG, Merck & Co Inc, Catalent Inc, Zoetis Inc, Johnson & Johnson, Embecta Corp, Astrazeneca PLC, Pfizer Inc, Sanofi, Glaxosmithkline PLC, Viatris Inc. and Novo Nordisk A/S.
9/20/2024 Health Care Sector Pharmaceuticals Industry
$24,565
Change: -1.06%
Open: $24,662
High: $24,834
Low: $24,402
| Roche Holding AG (RHHBF) |
+2.72%
|
| Bristol-Myers Squibb Co (BMY) |
+0.80%
|
| Eli Lilly and Co (LLY) |
+0.70%
|
| Novartis AG (NVS) |
-0.03%
|
| Roche Holding AG (RHHBY) |
-0.03%
|
| Merck & Co Inc (MRK) |
-0.05%
|
| Catalent Inc (CTLT) |
-0.18%
|
| Zoetis Inc (ZTS) |
-0.31%
|
| Johnson & Johnson (JNJ) |
-0.40%
|
| Embecta Corp (EMBC) |
-0.64%
|
| Astrazeneca PLC (AZN) |
-0.66%
|
| Pfizer Inc (PFE) |
-0.81%
|
| Pharmaceuticals Industry |
-1.06%
|
| Sanofi (SNY) |
-1.08%
|
| Glaxosmithkline PLC (GSK) |
-1.97%
|
| Viatris Inc. (VTRS) |
-4.29%
|
| Novo Nordisk A/S (NVO) |
-5.46%
|
Index Value: $24,565 -1.06%
Volume: 4.15B Average Volume (3 month): 2.36B
Market Capitalization: $53.32T
EBITDA: $6.76T
PEG Ratio (5 year Expected): 18.39
Dividend Yield: 3.19%
Dividend Rate: $643.88
Dividend Yield (Forward): 2.36%
Dividend Rate (Forward): $475.41
Shares Outstanding: 707.55B
Book Value: $4,733
Short Ratio: 1.37
Price Target (1 year): $21,512
Volume: 4.15B Average Volume (3 month): 2.36B
Market Capitalization: $53.32T
EBITDA: $6.76T
PEG Ratio (5 year Expected): 18.39
Dividend Yield: 3.19%
Dividend Rate: $643.88
Dividend Yield (Forward): 2.36%
Dividend Rate (Forward): $475.41
Shares Outstanding: 707.55B
Book Value: $4,733
Short Ratio: 1.37
Price Target (1 year): $21,512
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| RHHBF | Roche Holding AG | 329.79 | +2.72% | 4 | N/A | 0.00% |
| BMY | Bristol-Myers Squibb Co | 49.41 | +0.80% | 11.76M | 0.84 | 3.14% |
| LLY | Eli Lilly and Co | 921.49 | +0.70% | 3.88M | 1.23 | 27.41% |
| NVS | Novartis AG | 115.94 | -0.03% | 1.04M | 0.85 | 7.10% |
| RHHBY | Roche Holding AG | 39.45 | -0.03% | 1.40M | N/A | 0.01% |
| MRK | Merck & Co Inc | 117.17 | -0.05% | 21.19M | 2.15 | 9.30% |
| CTLT | Catalent Inc | 60.00 | -0.18% | 3.54M | 1.90 | 0.34% |
| ZTS | Zoetis Inc | 192.64 | -0.31% | 3.52M | 1.76 | 2.73% |
| JNJ | Johnson & Johnson | 164.16 | -0.40% | 5.03M | 0.75 | 12.37% |
| EMBC | Embecta Corp | 15.61 | -0.64% | 1.47M | 3.50 | 0.03% |
| AZN | Astrazeneca PLC | 78.38 | -0.66% | 3.33M | 0.75 | 7.61% |
| PFE | Pfizer Inc | 29.42 | -0.81% | 56.84M | 1.80 | 5.22% |
| Pharmaceuticals Industry | 24,565.13 | -1.06% | 4.15B | 1.76 | 44.20% | |
| SNY | Sanofi | 57.63 | -1.08% | 1.92M | 0.91 | 4.52% |
| GSK | Glaxosmithkline PLC | 40.80 | -1.97% | 4.96M | 1.38 | 2.60% |
| VTRS | Viatris Inc. | 11.39 | -4.29% | 46.90M | 5.66 | 0.43% |
| NVO | Novo Nordisk A/S | 127.51 | -5.46% | 9.24M | 2.45 | 17.20% |
| Symbol | Security | Market Cap | Div Yield | PEG Ratio |
| RHHBF | Roche Holding AG | 264.893B | 2.70% | |
| BMY | Bristol-Myers Squibb Co | 98.207B | 4.84% | -12.18 |
| LLY | Eli Lilly and Co | 857.179B | 0.51% | 0.76 |
| NVS | Novartis AG | 238.111B | 3.35% | 2.06 |
| RHHBY | Roche Holding AG | 265.405B | 23.15% | 3.56 |
| MRK | Merck & Co Inc | 294.114B | 2.61% | 0.17 |
| CTLT | Catalent Inc | 10.752B | 9.17 | |
| ZTS | Zoetis Inc | 82.863B | 0.88% | 3.30 |
| JNJ | Johnson & Johnson | 388.601B | 3.00% | 2.89 |
| EMBC | Embecta Corp | 774.935M | 4.42% | |
| AZN | Astrazeneca PLC | 265.282B | 3.49% | 1.61 |
| PFE | Pfizer Inc | 164.504B | 5.74% | 0.72 |
| Pharmaceuticals Industry | $53.32T | 3.19% | 18.39 | |
| SNY | Sanofi | 138.412B | 6.86% | 1.43 |
| GSK | Glaxosmithkline PLC | 85.352B | 1.44% | 2.12 |
| VTRS | Viatris Inc. | 13.988B | 4.12% | -1.37 |
| NVO | Novo Nordisk A/S | 596.997B | 7.29% | 94.18 |
Back to Market Summary